APSR2026-442

 
Late-Breaking
Submitted
Poster Presentation
 
AP05-020
P123
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1202428-46904-APSR 2026 AP05 020 BTVA Dr Izzah Hamzah_439488.pdf
Format: PDF Only
12. Bronchoscopy and Interventional Techniques
4

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Izzah Hamzah * Hospital Sultanah Aminah Jabatan Perubatan Respiratori Johor Bahru Malaysia
Rozanah Abd Rahman - Hospital Sultanah Aminah Jabatan Perubatan Respiratori Johor Bahru Malaysia
Suat Yee Lim - Hospital Sultanah Aminah Jabatan Perubatan Respiratori Johor Bahru Malaysia
Bazli Bahar - Hospital Sultanah Aminah Jabatan Perubatan Respiratori Johor Bahru Malaysia
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Izzah
Hamzah
ihamzah2011@gmail.com
+60137440709
41-50
Malaysia
Case Report
Bronchoscopic Thermal Vapor Ablation (BTVA): A Life-Changing Intervention for Heterogeneous Upper-Lobe Predominant Emphysema
Maximum 25 words
Abstract Content
 
 
 
 
Management of advanced Chronic Obstructive Pulmonary Disease (COPD) remains challenging when pharmacological optimization fails. While Lung Volume Reduction Surgery (LVRS) is established for heterogeneous upper-lobe emphysema, many patients are poor surgical candidates due to severe hyperinflation and comorbidities.
A 61-year-old male, a former heavy smoker (30 pack-years), presented with severe COPD (FEV1 37% predicted) and frequent exacerbations (3–4 times annually). Despite stepping up to triple therapy (LAMA/LABA/ICS) and methylxanthines, his condition deteriorated by 2025 to mMRC grade 4, becoming wheelchair-bound and dependent on daily home nebulization. Investigations revealed severe air trapping (TLC 134%, RV/TLC 78.53%) and a low DLCO of 24%. HRCT demonstrated extensive bilateral bullous emphysematous changes with low fissure integrity (<20%), rendering him unsuitable for Lung Endobronchial Valves (LEBV). A Multidisciplinary Team (MDT) recommended Bronchoscopic Thermal Vapor Ablation (BTVA) targeting the right upper lobe (RB2 and RB3). Following BTVA in June 2025, the patient showed remarkable clinical improvement. By December 2025, he no longer required a wheelchair or daily home nebulization. His dyspnea improved to mMRC 2–3, and reliever use decreased to once daily.
This case highlights the efficacy of BTVA as a minimally invasive alternative for patients with severe, heterogeneous emphysema and incomplete fissures. It underscores the importance of physiological and radiological phenotyping—specifically identifying upper-lobe predominance and gas trapping—to select patients for bronchoscopic lung volume reduction when medical therapy is exhausted.
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Chronic obstructive pulmonary disease, Bronchoscopic Thermal Vapour Ablation, Severe Emphysema
maximum 3 keywords and no abbreviations, separated by commas
 
232